Apelin Antagonizes Myocardial Impairment in Sepsis

Journal of Cardiac Failure

Volumn 16, Issue 7, 2010, Pages 609-617

  Pan, Chun Shui ^a   Teng, Xu ^a   Zhang, Jing ^c   Cai, Yan ^a   Zhao, Jing ^a   Wu, Wei ^a   Wang, Xian ^a,b   Tang, Chao Shu ^a,b   Qi, Yong Fen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Apelin; IL 8; MCP 1; rat; sepsis

Indexed keywords

APELIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HEART FUNCTION; HEART MUSCLE; INFLAMMATION; MALE; MEDIATOR RELEASE; MYOCARDIAL DISEASE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; WESTERN BLOTTING;

ANIMALS; CARDIOMYOPATHIES; CARRIER PROTEINS; CELLS, CULTURED; DOWN-REGULATION; MACROPHAGES, PERITONEAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 77953724332     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.02.002     Document Type: Article

References (45)

1. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003) 138-150
2. Cavaillon J.M., Adib-Conquy M., Fitting C., Adrie C., and Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 35 (2003) 535-544
3. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251 (1998) 471-476
4. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107 (2005) 198-211
5. De Mota N., Reaux-Le Goazigo A., El Messari S., Chartrel N., Roesch D., Dujardin C., et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A 101 (2004) 10464-10469
6. Reaux-Le Goazigo A., Morinville A., Burlet A., Llorens-Cortes C., and Beaudet A. Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145 (2004) 4392-4400
7. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538 (2001) 162-171
8. O'Carroll A.M., Selby T.L., Palkovits M., and Lolait S.J. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492 (2000) 72-80
9. Hosoya M., Kawamata Y., Fukusumi S., Fujii R., Habata Y., Hinuma S., et al. Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275 (2000) 21061-21067
10. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., et al. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20 (2006) 1528-1530
11. García-Díaz D., Campión J., Milagro F.I., and Martínez J.A. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 305 (2007) 87-94
12. Szokodi I., Tavi P., Földes G., Voutilainen-Myllylä S., Ilves M., Tokola H., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91 (2002) 434-440
13. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65 (2005) 73-82
14. Chong K.S., Gardner R.S., Morton J.J., Ashley E.A., and McDonagh T.A. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail 8 (2006) 355-360
15. Miettinen K.H., Magga J., Vuolteenaho O., Vanninen E.J., Punnonen K.R., Ylitalo K., et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy. Regul Pept 140 (2007) 178-184
16. Kuba K., Zhang L., Imai Y., Arab S., Chen M., Maekawa Y., et al. Impaired heart contractility in apelin gene-deficient mice associated with aging and pressure overload. Circ Res 101 (2007) e32-e42
17. Berry M.F., Pirolli T.J., Jayasankar V., Burdick J., Morine K.J., Gardner T.J., et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 (2004) II187-II193
18. Esposito V., De Falco M., De Luca L., Acanfora F., Onori N., Loiacono L., et al. Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia. Vivo 16 (2002) 337-340
19. Horiuchi Y., Fujii T., Kamimura Y., and Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. J Neuroimmunol 144 (2003) 46-52
20. Tang C., and Liu M. Initial externalization followed by internalization of β-adrenergic receptors in rat heart during sepsis. Am J Physiol 270 (1996) R254-R263
21. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318 (2004) 756-763
22. Qi Y.F., Bu D.F., Niu D.D., Shi Y.R., Wang S.H., Pang Y.Z., et al. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 23 (2002) 1141-1147
23. Kulhanek-Heinze S., Gerbes A.L., Gerwig T., Vollmar A.M., and Kiemer A.K. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers. J Hepatol 41 (2004) 414-420
24. Zou M.X., Liu H.Y., Haraguchi Y., Soda Y., Tatemoto K., and Hoshino H. Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett 473 (2000) 15-18
25. Wang P., Zhou M., Rana M.W., Ba Z.F., and Chaudry I.H. Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol 263 (1992) G38-G43
26. Yang S., Cioffi W.G., Bland K.I., Chaudry I.H., and Wang P. Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J Trauma 47 (1999) 706-712
27. Földes G., Horkay F., Szokodi I., Vuolteenaho O., Ilves M., Lindstedt K.A., et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308 (2003) 480-485
28. Wei L., Hou X., and Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 132 (2005) 27-32
29. O'Carroll A.M., Don A.L., and Lolait S.J. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J Neuroendocrinol 15 (2003) 1095-1101
30. Dai T., Ramirez-Correa G., and Gao W.D. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553 (2006) 222-228
31. Simpkin J.C., Yellon D.M., Davidson S.M., Lim S.Y., Wynne A.M., and Smith C.C. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia reperfusion injury. Basic Res Cardiol 102 (2007) 518-528
32. Farkasfalvi K., Stagg M.A., Coppen S.R., Siedlecka U., Lee J., Soppa G.K., et al. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357 (2007) 889-895
33. Maeder M., Fehr T., Rickli H., and Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129 (2006) 1349-1366
34. Russell J.A. Management of sepsis. N Engl J Med 355 (2006) 1699-1713
35. Perl M., Chung C.S., Garber M., Huang X., and Ayala A. Contribution of anti-inflammatory/ immune suppressive processes to the pathology of sepsis. Front Biosci 11 (2006) 272-299
36. Edingeral, Hoffman T.L., Sharronm M., Lee B., Yi Y., Choe W., et al. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 71 (1998) 7934-7940
37. Choe W., Albright A., Sulcove J., Jaffer S., Hesselgesser J., Lavi E., et al. Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol 6 (2000) S61-S69
38. Leeper N.J., Tedesco M.M., Kojima Y., Schultz G.M., Kundu R.K., Ashley E.A., et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol 296 (2009) H1329-H1335
39. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Buléon M., et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8 (2008) 437-445
40. Guo L., Li Q., Wang W., Yu P., Pan H., Li P., Sun Y., and Zhang J. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr Res 34 (2009) 142-154
41. Sörhede Winzell M., Magnusson C., and Ahrén B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131 (2005) 12-17
42. Bossink A.W., Paemen L., Jansen P.M., Hack C.E., Thijs L.G., and Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86 (1995) 3841-3847
43. Friedland J.S., Suputtamongkol Y., Remick D.G., Chaowagul W., Strieter R.M., Kunkel S.L., et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 60 (1992) 2402-2408
44. Roberts E.M., Newson M.J., Pope G.R., Landgraf R., Lolait S.J., and O'Carroll A.M. Abnormal fluid homeostasis in apelin receptor knockout mice. J Endocrinol 202 (2009) 453-462
45. Charo D.N., Ho M., Fajardo G., Kawana M., Kundu R.K., Sheikh A.Y., et al. Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol 297 (2009) H1904-H1913